AMPH
Price
$39.17
Change
-$1.68 (-4.11%)
Updated
Dec 18, 04:06 PM (EDT)
84 days until earnings call
EOLS
Price
$11.24
Change
-$0.49 (-4.18%)
Updated
Dec 18, 04:12 PM (EDT)
70 days until earnings call
Ad is loading...

AMPH vs EOLS

Header iconAMPH vs EOLS Comparison
Open Charts AMPH vs EOLSBanner chart's image
Amphastar Pharmaceuticals
Price$39.17
Change-$1.68 (-4.11%)
Volume$850
CapitalizationN/A
Evolus
Price$11.24
Change-$0.49 (-4.18%)
Volume$333
CapitalizationN/A
AMPH vs EOLS Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. EOLS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and EOLS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (AMPH: $40.85 vs. EOLS: $11.73)
Brand notoriety: AMPH and EOLS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 127% vs. EOLS: 101%
Market capitalization -- AMPH: $2.11B vs. EOLS: $846.82M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. EOLS’s [@Pharmaceuticals: Other] market capitalization is $846.82M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileEOLS’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • EOLS’s FA Score: 0 green, 5 red.
According to our system of comparison, AMPH is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while EOLS’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 6 bearish.
  • EOLS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AMPH and EOLS are a bad buy in the short-term.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -6.39% price change this week, while EOLS (@Pharmaceuticals: Other) price change was -2.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.62%. For the same industry, the average monthly price growth was +2.81%, and the average quarterly price growth was -7.89%.

Reported Earning Dates

AMPH is expected to report earnings on Mar 12, 2025.

EOLS is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.62% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than EOLS($847M). EOLS YTD gains are higher at: 11.396 vs. AMPH (-33.953). AMPH has higher annual earnings (EBITDA): 240M vs. EOLS (-41.81M). AMPH has more cash in the bank: 257M vs. EOLS (62.8M). EOLS has less debt than AMPH: EOLS (127M) vs AMPH (624M). AMPH has higher revenues than EOLS: AMPH (644M) vs EOLS (202M).
AMPHEOLSAMPH / EOLS
Capitalization2.11B847M249%
EBITDA240M-41.81M-574%
Gain YTD-33.95311.396-298%
P/E Ratio16.69N/A-
Revenue644M202M319%
Total Cash257M62.8M409%
Total Debt624M127M491%
FUNDAMENTALS RATINGS
AMPH vs EOLS: Fundamental Ratings
AMPH
EOLS
OUTLOOK RATING
1..100
6574
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
40100
SMR RATING
1..100
40100
PRICE GROWTH RATING
1..100
6361
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (68) in the Pharmaceuticals Other industry is in the same range as EOLS (97) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to EOLS’s over the last 12 months.

AMPH's Profit vs Risk Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for EOLS (100) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew somewhat faster than EOLS’s over the last 12 months.

AMPH's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for EOLS (100) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew somewhat faster than EOLS’s over the last 12 months.

EOLS's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as AMPH (63) in the Pharmaceuticals Other industry. This means that EOLS’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as EOLS (100) in the Pharmaceuticals Major industry. This means that AMPH’s stock grew similarly to EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHEOLS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
73%
Bullish Trend 22 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNMIX14.34N/A
N/A
Manning & Napier Pro-Blend Mod Term I
GSATX35.14N/A
N/A
Goldman Sachs Small Cp Val Insghts A
EIPFX18.81N/A
N/A
EIP Growth and Income Investor
LGMNX26.96-0.15
-0.55%
Loomis Sayles Global Allocation N
VSGAX103.50-1.06
-1.01%
Vanguard Small Cap Growth Index Admiral

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with SUPN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.02%
SUPN - AMPH
35%
Loosely correlated
-0.74%
DVAX - AMPH
31%
Poorly correlated
+0.39%
EOLS - AMPH
28%
Poorly correlated
+1.91%
HROW - AMPH
28%
Poorly correlated
-4.27%
VTRS - AMPH
28%
Poorly correlated
+0.48%
More

EOLS and

Correlation & Price change

A.I.dvisor tells us that EOLS and AMPH have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EOLS and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
+1.91%
AMPH - EOLS
28%
Poorly correlated
+0.02%
ACET - EOLS
26%
Poorly correlated
-0.75%
EVOK - EOLS
26%
Poorly correlated
+0.03%
SNDL - EOLS
25%
Poorly correlated
+4.17%
LFCR - EOLS
23%
Poorly correlated
-3.74%
More